South African Health Minister Nkosazana Zuma has bowed to public pressure, and a court challenge from SmithKline Beecham (Marketletter October 7), by withdrawing radical plans to curb doctors' drug dispensing rights and make generic prescribing mandatory.
Just hours before the court deadline expired on October 17, the State Attorney's Office confirmed that it had been instructed by the Health Department to settle its legal dispute with SB on the grounds that the regulations had been withdrawn. The instruction to settle was followed by a Health Ministry statement announcing that the regulations would be withdrawn and redrafted to take into account some of the over 300 submissions which had been received. SB, which was threatened with being put out of business in South Africa if it did not drop its action against the Minister, had asked the Supreme Court of Transvaal to declare the regulations ultra vires and void.
The regulations would have affected some 6,000 registered dispensing doctors and about three million patients. They would have required doctors to be licensed every year and to pass dispensing examinations, prevented them from dispensing if there was a pharmacy nearby (the distance was not stipulated), and made provision for more stringent control over storage and labeling of medicines. The doctors responded by forming a coalition called the National Convention on Dispensing to protect their rights, and condemned the "punitive" proposals, claiming that they would be counterproductive and drive up the costs of medicine for the poorest sectors of the community.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze